PainReform share price logo

PainReform

NASDAQ: PRFX

$0.86

-0.02

(-2.16%)

as on

PainReform Stock Performance

as on October 9, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.85
    $0.89
    downward going graph

    1.01%

    Downside

    3.65%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.85
    $7.95
    downward going graph

    0.89%

    Downside

    825.82%

    Upside

    downward going graph

PainReform share price movements today

Previous Close
$0.88
Open
$0.89
Volume
74.3K
Market Cap
$3.1M
Day's Low - High
$0.85 - $0.89
52 Week Low - High
$0.85 - $7.95

PainReform Historical Returns

1 Month Return
-9.64 %
3 Month Return
-39.53 %
1 Year Return
-87.99 %
3 Year Return
-99.76 %
5 Year Return
-99.97 %

PainReform Stock Fundamentals & Key Indicators

Check PainReform market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1M

EPS (TTM)

-11.16

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.08

Industry PE ratio

-6.43

PEG Ratio

-0.00

EBITDA

-7.4M

Revenue (TTM)

39.5K

Profit Margin

-307.59%

Return On Equity TTM

-72.87%

PainReform vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PainReform with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$3.1M-99.97%-0.08-307.59%0.00%
Buy$36.9BNA57.0047.54%1.21%
Buy$23.4B172.69%18.0386.14%0.00%
Buy$20.1B27.95%-48.5834.83%2.74%
Buy$38.8BNA18.8865.57%1.37%

Stock Returns calculator for PainReform Stock including INR - Dollar returns

The PainReform stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

PainReform investment value today

Current value as on today

₹13,095

Returns

-₹86,905

(-86.91%)

Returns from PainReform Stock

-₹87,990 (-87.99%)

Dollar Impact

₹1,085 (+1.09%)

Analyst Recommendation on PainReform Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for PainReform. Average target price of $12

PainReform Share Price Target

Get share price movements and forecasts by analysts on PainReform.

What analysts predicted

92.84%UPSIDE

Target Price

$12

Current Price

$0.8587

Analyzed by

7 Analysts

Target

$12.00

PainReform target price $12, a slight upside of 92.84% compared to current price of $0.8587. According to 7 analysts rating.

Indian Investors' Interest in PainReform Stock

Search interest for PainReform Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:47% versus previous 30 day period

PainReform Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
0
0
0
0
Gross Profit
-
-
-
-
-
0
0
0
0
Operating Income
-7
0
0
-1
-1
-1
-5
-1
-1
EBITDA
-7
0
0
-1
-1
-1
-4
-1
-1
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
0
0
-1
-1
-1
-5
-1
-1
Income Tax Expense
-
0
0
-
-
0
0
0
0
Net Income
-7
0
0
-1
-1
-1
-4
-1
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-311.76%
-311.76%
-300.00%
-300.00%

PainReform Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
0
-
-
0
Gross Profit
-
-
-
-
-
0
0
0
0
Operating Income
0
0
0
-1
-7
-8
-9
-14
-4
EBITDA
-
0
0
-1
-7
-8
-9
-14
-4
Interest Expense
-
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
0
-1
-3
-7
-8
-9
-14
-5
Income Tax Expense
-
0
-
0
0
0
0
0
0
Net Income
-2
0
-1
-4
-7
-8
-9
-14
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
82.56%
0.00%
0.00%
-4864.71%

PainReform Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-7
0
0
-1
-1
-1
-5
-1
-1
Operating Cash Flow
-3
-4
-1
-1
0
0
0
-3
-1
-1
Investing Cash Flow
0
0
0
0
0
0
0
0
-1
-1
Financing Cash Flow
-
3
2
2
0
0
1
3
4
4
Change in Cash
-3
-1
-2
-
-
-
-
-1
-
-

PainReform Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
0
-1
-4
-7
-8
-9
-14
-5
Operating Cash Flow
0
0
0
-2
-6
-6
-6
-12
-3
Investing Cash Flow
-
-
-
0
0
-6
5
0
0
Financing Cash Flow
0
0
1
17
7
-
4
8
3
Change in Cash
0
0
0
14
0
-12
3
-3
0

Global Institutional Holdings in PainReform

Check out the Institutions with significant holdings in PainReform.

Funds
Holdings
TWO SIGMA SECURITIES, LLC
0.00%
UBS Group AG
0.03%
Advisor Group Holdings, Inc.
0.00%
Rockefeller Capital Management L.P.
0.00%
Apollon Wealth Management, LLC
0.00%

Insights on PainReform

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 80.5% return, outperforming this stock by 180.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 74.6% return, outperforming this stock by 162.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, PRFX stock has moved down by -64.4%

About PainReform

PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
OrganisationPainReform
Headquarters65 Yigal Alon Street, Tel Aviv, TA, 6744316, IL
IndustryDrug Manufacturers - Specialty & Generic
CEOEfraim Cohen-Arazi

Key Management of PainReform

Name

Title

Dr. Ehud Geller Ph.D.

Executive Chairman

Mr. Eyal Broder

Chief Financial Officer

Dr. Sigal Aviel eMBA, Ph.D.

Chief Operating Officer

Mr. Efraim Cohen-Arazi

Interim CEO & Director

Ms. Rita Keynan M.Sc.

Vice President of Pharmaceutical Operations

FAQs

What is PainReform share price today?

PainReform share price today is $0.86 as on at the close of the market. PainReform share today touched a day high of $0.89 and a low of $0.85.

What is the 52 week high and 52 week low for PainReform share?

PainReform share touched a 52 week high of $7.95 on and a 52 week low of $0.85 on . PainReform stock price today i.e. is closed at $0.86,which is 89.20% down from its 52 week high and 0.89% up from its 52 week low.

What is PainReform's market capitalisation today?

PainReform market capitalisation is $0.00T as on .

How to invest in PainReform Stock (PRFX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PainReform on INDmoney app. Click on Buy button.

What is the minimum amount required to buy PainReform Stock (PRFX) from India?

Indian investors can start investing in PainReform (PRFX) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in PainReform stock (as per the Rupee-Dollar exchange rate as on ). Based on PainReform share’s latest price of $0.86 as on October 9, 2026 at 8:45 am IST, you will get 11.6455 shares of PainReform. Learn more about fractional shares .

What are the returns that PainReform has given to Indian investors in the last 5 years?

PainReform stock has given -99.97% share price returns and 28.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?